The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain
Open accessAbstract
Direct-acting cannabinoid receptor agonists are well known to reduce hyperalgesic responses and allodynia after nerve injury, although their psychoactive side effects have damped enthusiasm for their therapeutic development. Alternatively, inhibiting fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL), the principal enzymes responsible for the degradation of the respective endogenous cannabinoids, anandamide (AEA) and 2-arachydonylglycerol (2-AG), reduce nociception in a variety of nociceptive assays, with no or minimal behavioral effects. In the present study we tested whether inhibition of these enzymes attenuates mechanical allodynia, and acetone-induced cold allodynia in mice subjected to chronic constriction injury of the sciatic nerve. Acute administration of the irreversible FAAH inhibitor, cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597), or the reversible FAAH inhibitor, 1-oxo-1-[5-(2-pyridyl)-2-yl]-7-phenylheptane (OL-135), decreased allodynia in both tests. This attenuation was completely blocked by pretreatment with either CB(1) or CB(2) receptor antagonists, but not by the TRPV1 receptor antagonist, capsazepine, or the opioid receptor antagonist, naltrexone. The novel MAGL inhibitor, 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) also attenuated mechanical and cold allodynia via a CB(1), but not a CB(2), receptor mechanism of action. Whereas URB597 did not elicit antiallodynic effects in FAAH(-/-) mice, the effects of JZL184 were FAAH-independent. Finally, URB597 increased brain and spinal cord AEA levels, whereas JZL184 increased 2-AG levels in these tissues, but no differences in either endo-cannabinoid were found between nerve-injured and control mice. These data indicate that inhibition of FAAH and MAGL reduces neuropathic pain through distinct receptor mechanisms of action and present viable targets for the development of analgesic therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“though ceiling effects and other methodological differences between studies may have precluded the detection of enhanced nociceptive behavior.”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Kinsey et al, 2009
In the citing paper
“However, other studies using knockout mice or selective inhibitors of CB 1 or CB 2 receptors show no alterations of nociceptive behavior in neuropathic pain models (Kinsey et al, 2009(Kinsey et al, , 2010) ) though ceiling effects and other methodological differences between studies may have precluded the detection of enhanced nociceptive behavior.”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Kinsey et al, 2009
In the citing paper
“Additionally both OL135 and URB597 are antinociceptive in FAAH+/+ mice, but fail to produce an effect in FAAH-/- mice.59”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [59]
In the citing paper
“OL135 and URB597 attenuate cold and mechanical allodynia in a manner that is dependent upon activation of both CB1 and CB2 receptors.59”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [59]
In the citing paper
“The novel MGL inhibitor, JZL184, attenuates CCI-induced mechanical and cold allodynia through indirect activation of the CB1 receptor; JZL184 was efficacious in attenuating neuropathic nociception in both FAAH+/+ and FAAH-/- mice.59”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantitative assessment of tactile allodynia in the rat paw
Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M., & Yaksh, T. L. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90144-9 · Cited by 7,740
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Spared nerve injury: an animal model of persistent peripheral neuropathic pain
Décosterd, I., & Woolf, C. J. (2000) · Pain · doi:10.1016/s0304-3959(00)00276-1 · Cited by 2,317
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Self-citationGaliègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,776
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310
Self-citationModulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Samad, T. A., Moore, K. A., Sapirstein, A., Billet, S. E., Allchorne, A. J., Poole, S., Bonventre, J. V., & Woolf, C. J. (2001) · Nature · doi:10.1038/35068566 · Cited by 1,282
Cited by
Sorted by citations
Items 201–300 of 345
Petrenko, A. B., Yamazaki, M., Sakimura, K., Kano, M., & Baba, H. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.063 · Cited by 17
Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease
Khasabova, I. A., Gable, J., Johns, M. E., Khasabov, S. G., Kalyuzhny, A. E., Golovko, M. Y., Golovko, S. A., Kiven, S. B., Gupta, K., Seybold, V. S., et al. (2022) · Haematologica · doi:10.3324/haematol.2021.280460 · Cited by 17
Straub, V. M., Barti, B., Tandar, S. T., Stevens, A. F., van Egmond, N., van der Wel, T., Zhu, N., Rüegger, J., van der Horst, C., Heitman, L. H., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2421717122 · Cited by 18
Chemical approaches to study metabolic networks
Medina-Cleghorn, D. A., & Nomura, D. K. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1201-0 · Cited by 17
Summers, T. L., Hanten, B., Peterson, W., & Burrell, B. D. (2017) · Scientific Reports · doi:10.1038/s41598-017-06114-1 · Cited by 18
CB2 Receptors and Neuron–Glia Interactions Modulate Neurotoxicity Generated by MAGL Inhibition
Rojo-Bustamante, E., Íñigo-Marco, I., Abellanas, M. A., Vinueza‐Gavilanes, R., Baltanás, A., Luquin, E., Arrasate, M., & Aymerich, M. S. (2020) · Biomolecules · doi:10.3390/biom10081198 · Cited by 17
2-Amino-5-arylbenzoxazole derivatives as potent inhibitors of fatty acid amide hydrolase (FAAH)
Estiarte, M. A., Johnson, R. J. K., Kaub, C. J., Gowlugari, S., O’Mahony, D. J. R., Nguyen, M. T. L., Emerling, D. E., Kelly, M. G., Kincaid, J., Vincent, F., et al. (2012) · MedChemComm · doi:10.1039/c2md00307d · Cited by 17
Lakis, V., Chan, N. L., Lyons, R. J., Blackburn, N., Nguyen, T. H., Nguyen, T., Masel, A., Masel, A. M., Boyle, G. M., Patch, A., et al. (2025) · Cancers · doi:10.3390/cancers17050852 · Cited by 16
Nass, S. R., Long, J. Z., Schlosburg, J. E., Cravatt, B. F., Lichtman, A. H., & Kinsey, S. G. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9593-1 · Cited by 16
Self-citationCastelli, R., Scalvini, L., Vacondio, F., Lodola, A., Anselmi, M., Vezzosi, S., Carmi, C., Bassi, M., Ferlenghi, F., Rivara, S., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01679 · Cited by 18
Altamimi, A. S. A., Bawa, S., Athar, F., Hassan, M. Q., Riadi, Y., & Afzal, O. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13751 · Cited by 16
Kamimura, R., Hossain, M. Z., Unno, S., Ando, H., Masuda, Y., TAKAHASHI, K., Otake, M., Saito, I., & Kitagawa, J. (2018) · Journal of Oral Science · doi:10.2334/josnusd.17-0005 · Cited by 16
Szabó, M., Agostino, M., Malone, D. T., Yuriev, E., & Capuano, B. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.09.038 · Cited by 16
Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence
Sokolaj, E. E., Assareh, N., Anderson, K. E., Aubrey, K. R., & Vaughan, C. W. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15964 · Cited by 16
Scott, C. W., Tian, G., Yu, X. H., Paschetto, K. A., Wilkins, D. E., Meury, L., Cao, C. Q., Varnes, J. G., & Edwards, P. D. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.052 · Cited by 15
Karageorgos, I. L., Tyukhtenko, S. I., Zvonok, N., Janero, D. R., Sallum, C. O., & Makriyannis, A. (2010) · Molecular BioSystems · doi:10.1039/c004515b · Cited by 15
Yeşilyurt, Ö., Çayırlı, M., Sakın, Y. S., Seyrek, M., Akar, A., & Dogrul, A. B. (2016) · Archives of Dermatological Research · doi:10.1007/s00403-016-1649-4 · Cited by 15
Lafreniere, J. D., & Kelly, M. E. M. (2018) · Neuronal Signaling · doi:10.1042/ns20170144 · Cited by 16
Yoga: Can it be integrated with treatment of neuropathic pain?
Telles, S., Sayal, N., Nacht, C. L., Chopra, A., Patel, K., Wnuk, A., Dalvi, P. S., Bhatia, K., Miranpuri, G. S., & Anand, A. (2019) · Annals of Neurosciences · doi:10.5214/ans.0972.7531.260208 · Cited by 15
Hama, A. T., Germano, P., Varghese, M. S., Cravatt, B. F., Milne, G. T., Pearson, J. P., & Sagen, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096396 · Cited by 15
Self-citationZhong, S., Zhou, Z., Lin, X., Liu, F., Liu, C., Liu, Z., Deng, W., Zhang, X., Chang, H., & Zhao, C. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15397 · Cited by 14
Lee, M. T., Mackie, K., & Chiou, L. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15771 · Cited by 16
No more pain upon G q‐protein‐coupled receptor activation: role of endocannabinoids
Hu, S. S., Ho, Y., & Chiou, L. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12475 · Cited by 16
RetractedNew therapeutic potential for psychoactive natural products
Prevatt‐Smith, K. M., & Prisinzano, T. E. (2009) · Natural Product Reports · doi:10.1039/b912196j · Cited by 14
Jones, M., Wen, J., Selvaraj, P., Tanaka, M., Moran, S., & Zhang, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01481 · Cited by 14
Dodu, J. C., Moncayo, R. K., Damaj, M. I., Schlosburg, J. E., Akbarali, H. I., Schurman, L. D., Kendall, D. A., Wu, Z., Lu, D., & Lichtman, A. H. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000723 · Cited by 13
Self-citationVeloso, C. C., Ferreira, R. C. M., Rodrigues, V. G., Duarte, L. P., Klein, A., Duarte, I. D. G., Romero, T. R. L., & Perez, A. C. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0391-7 · Cited by 13
Diester, C. M., Lichtman, A. H., & Negus, S. S. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000497 · Cited by 13
Self-citationBeaudette-Zlatanova, B. C., Lew, R., Otis, J. D., Branch‐Elliman, W., Bacorro, E., Dubreuil, M., Eyvazzadeh, C., Kaur, M., Lazzari, A. A., Libbey, C. A., et al. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.03.013 · Cited by 12
Hentsch, A., Guberman, M., Radetzki, S., Kaushik, S., Huizenga, M. C. W., He, Y., Contzen, J., Kuhn, B., Benz, J., Schippers, M., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c15223 · Cited by 13
Matuszak, N., Saadi, B. E., Labar, G., Marchand‐Brynaert, J., & Lambert, D. M. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.026 · Cited by 12
Rahmani, M.-R., Shamsizadeh, A., Ahmadi, A. M., Kaeidi, A., & Allahtavakoli, M. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.02.036 · Cited by 12
Metabolomic strategies to map functions of metabolic pathways
Mulvihill, M. M., & Nomura, D. K. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00228.2014 · Cited by 12
Kuhn, B., Ritter, M., Hornsperger, B., Bell, C., Koçer, B., Rombach, D., Lutz, M. D. R., Gobbi, L. B., Kuratli, M., Bartelmus, C., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01769 · Cited by 13
Dócs, K., Hegyi, Z., Holló, K., Kis, G. N., Hegedűs, K., & Antal, M. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0813-x · Cited by 11
Hamilton, A. J., Payne, A. D., Mocerino, M., & Gunosewoyo, H. (2021) · Australian Journal of Chemistry · doi:10.1071/ch21007 · Cited by 11
Endocannabinoid Enzyme Engineering: Soluble Human Thio-Monoacylglycerol Lipase (sol-S-hMGL)
Karageorgos, I. L., Zvonok, N., Janero, D. R., Vemuri, K. V., Shukla, V. G., Wales, T. E., Engen, J. R., & Makriyannis, A. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000263 · Cited by 11
Zhang, D., Chen, D., Ma, S., Bian, W., Xie, F., Huang, M., Lin, H., Zhan, Q., & Zhao, G. (2019) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.587 · Cited by 11
Effects of Cannabis and Cannabinoids in the Human Nervous System
Kalant, H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00013-7 · Cited by 11
Kruk-Słomka, M., Dzik, A., & Biała, G. (2025) · Molecules · doi:10.3390/molecules30040867 · Cited by 10
Gpr83 Tunes Nociceptor Function, Controlling Pain
Kim, Y., Kim, C., Lee, H., Kim, M., Zheng, H., Lim, J. Y., Yun, H.-I., Jeon, M., Choi, J., & Hwang, S. W. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01327-3 · Cited by 10
Bai, X., Batallé, G., Martínez-Martel, I., & Pol, O. (2023) · Antioxidants · doi:10.3390/antiox12061179 · Cited by 9
Sase, A., Khan, D., Höger, H., & Lübec, G. (2011) · Amino Acids · doi:10.1007/s00726-011-1130-9 · Cited by 9
Fundamentals of and Critical Issues in Lipid Autacoid Medicine: A Review
Hesselink, J. M. K. (2017) · Pain and Therapy · doi:10.1007/s40122-017-0075-4 · Cited by 9
Carlo, S. D., Manera, C., Chicca, A., Arena, C., Bertini, S., Burgalassi, S., Tampucci, S., Gertsch, J., Macchia, M., & Saccomanni, G. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.02.007 · Cited by 9
Dean, C., Hillard, C. J., Seagard, J. L., Hopp, F. A., & Hogan, Q. H. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00481.2016 · Cited by 9
Ebrahimi-Ghiri, M., Shahini, F., Khakpai, F., & Zarrindast, M. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01676-5 · Cited by 9
Yadav-Samudrala, B. J., Ravula, H., Barmada, K. M., Dodson, H., Poklis, J. L., Ignatowska-Jankowska, B. M., Lichtman, A. H., Reissner, K. J., & Fitting, S. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0247 · Cited by 8
Self-citationSufian, M. S., Amin, M. R., & Ali, D. W. (2021) · Journal of Experimental Biology · doi:10.1242/jeb.242635 · Cited by 8
Becker, A., Geißlinger, G., Murín, R., Grecksch, G., Höllt, V., Zimmer, A., & Schröder, H. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0839-2 · Cited by 8
Duncan, K. K., Otrubova, K., & Boger, D. L. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.03.013 · Cited by 8
Self-citationEriksen, G. S., Jacobsen, L. M., Mahmood, A., Pedersen, L. M., & Gjerstad, J. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.11.009 · Cited by 7
Topuz, R. D., Gündüz, Ö., Karadağ, Ç. H., Dökmeci, D., & Ulugöl, A. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0015 · Cited by 7
Wen, J., Tanaka, M., & Zhang, Y. (2025) · The Journal of Headache and Pain · doi:10.1186/s10194-025-02116-x · Cited by 7
Hu, J., Fan, W., Xu, Y., Li, X., Zhang, H., Li, S., & Xue, L. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01345-6 · Cited by 6
Wang, T. (2015) · The Chinese Journal of Physiology · doi:10.4077/cjp.2015.bad307 · Cited by 6
Characterization of a Fatty Acid Amide Hydrolase (FAAH) in Hirudo Verbana
Kabeiseman, E. J., Paulsen, R. T., & Burrell, B. D. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04216-7 · Cited by 5
Aebi, J. D., Atz, K., Ametamey, S. M., Benz, J., Blaising, J., Butini, S., Campiani, G., Carreira, E. M., Collin, L., de Lago, E., et al. (2024) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2024.499 · Cited by 5
Discovery of novel reversible monoacylglycerol lipase inhibitors via docking-based virtual screening
Xiong, F., Ding, X., Zhang, H., Luo, X., Chen, K., Jiang, H., Luo, C., & Xu, H. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.127986 · Cited by 6
Pondelick, A. M., Moncayo, L. V., Donvito, G., McLane, V. D., Gillespie, J. C., Hauser, K. F., Spiegel, S., Lichtman, A. H., Sim‐Selley, L. J., & Selley, D. E. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110165 · Cited by 4
Self-citationJang, S.-Y., Jin, H.-L., Yu, G., Lim, D., & Park, W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188863 · Cited by 4
Kamimura, R., Hossain, M. Z., TAKAHASHI, K., Saito, I., & Kitagawa, J. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10034 · Cited by 4
Endocannabinoids rein in pain outside the brain
Lovinger, D. M. (2010) · Nature Neuroscience · doi:10.1038/nn1010-1155 · Cited by 4
Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice
Owens, R. A., Ignatowska-Jankowska, B. M., Mustafa, M. A., Beardsley, P. M., Wiley, J. L., Jali, A. M., Selley, D. E., Niphakis, M. J., Cravatt, B. F., & Lichtman, A. H. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.229492 · Cited by 5
Self-citationMikkelsen, J. D., Aripaka, S. S., Eğilmez, C. B., & Pazarlar, B. A. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105717 · Cited by 4
From Cannabis to the Endocannabinoid System: Refocussing Attention on Potential Clinical Benefits
Youssef, F. F., & Irving, A. J. (2012) · West Indian Medical Journal · doi:10.7727/wimj.2010.058 · Cited by 4
Yoga: Can It Be Integrated with Treatment of Neuropathic Pain
Telles, S., Sayal, N., Nacht, C. L., Chopra, A., Patel, K., Wnuk, A., Dalvi, P. S., Bhatia, K., Miranpuri, G. S., & Anand, A. (2017) · Integrative Medicine International · doi:10.1159/000463385 · Cited by 4
Modulation of central endocannabinoid system results in gastric mucosal protection in the rat
Tóth, V. É., Fehér, Á., Németh, J., Gyertyán, I., Zádori, Z., & Gyires, K. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.02.012 · Cited by 4
The “five-star matrix” for patient-centric drug discovery and development in neuroscience
Pähler, A., O’Connor, E. C., Binch, H., Dudal, S., Gobbi, L. B., Lübbers, T., Olivares‐Morales, A., Sarmiento, R. M. R., Grether, U., Ståhl, M., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.08.004 · Cited by 3
Tang, W. J., Wang, H.-J., Luo, S.-Y., Zhang, S., Xie, H., Chen, H.-Q., Wang, C., & Zhang, Z. (2024) · Bioengineering · doi:10.3390/bioengineering11111114 · Cited by 3
The Endocannabinoid System in Local and Systemic Inflammation
Kelly, M. E. M., Lehmann, C., & Zhou, J. (2017) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00151ed1v01y201702isp074 · Cited by 4
Karin, K. N., Mustafa, M. A., Lichtman, A. H., & Poklis, J. L. (2023) · Journal of Separation Science · doi:10.1002/jssc.202300395 · Cited by 3
Self-citationCascella, M., Peraro, M. D., & Vivo, M. D. (2015) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608058648115010010 · Cited by 3
Distinct endocannabinoids specifically signal to astrocytes and neuronsPreprint
Noriega‐Prieto, J. A., Falcón‐Moya, R., Eraso‐Pichot, A., Fundazuri, U. B., Guttipatti, P., Belisle, L., Moreno, A. R., van der Stelt, M., Cheer, J. F., Marsicano, G., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.13.544877 · Cited by 3
Design of arylfurans as potential FAAH inhibitors: therapeutic potential in pain management
Santana, P. A. L., de Matos, R. C., Bitencourt, A. F. A., Maltarollo, V. G., Aguiar, M. G., Machado, R. R., & de Oliveira, R. B. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118471 · Cited by 2
Anti-inflammatory and analgesic potential of minor cannabinoids in vivo
Vanegas, S. O., Gamage, T. F., Maturano, J., Šarlah, D., & Kinsey, S. G. (2026) · Journal of Cannabis Research · doi:10.1186/s42238-025-00384-7 · Cited by 2
Self-citationBourke, S. L., Suarez, E. G., Islam, B., Stephenson, J. R., Finn, D. P., & McHugh, P. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14351 · Cited by 2
Elevating Endogenous Cannabinoids Reduces Opioid Withdrawal in Mice
Ramesh, D. (2012) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/xdwb-4257 · Cited by 2
Reck, A. M., Siderovski, D. P., & Kinsey, S. G. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110216 · Cited by 2
Self-citationInhibitors of Fatty Acid Amide Hydrolase
Boger, D. L. (2012) · Springer eBooks · doi:10.1007/978-4-431-54038-0_4 · Cited by 2
Self-citationIgnatowska-Jankowska, B. M., Özer, A. G., Kuck, A., Niphakis, M. J., Ogasawara, D., Cravatt, B. F., & Uusisaari, M. Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.25.546437 · Cited by 2
Self-citationN-oleoyl alanine attenuates nicotine reward and spontaneous nicotine withdrawal in mice
Karin, K. N., Mustafa, M. A., Poklis, J. L., Buzzi, B., Schlosburg, J. E., Parker, L. A., Damaj, M. I., & Lichtman, A. H. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.111276 · Cited by 1
Self-citationIdentification of a Possible Endocannabinoid-Mediated Mechanism of Action of Cetylated Fatty Acids
Bononi, G., Granchi, C., Tuccinardi, T., & Minutolo, F. (2025) · Biomolecules · doi:10.3390/biom15030363 · Cited by 1
Ciechanowska, A., & Mika, J. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.120028 · Cited by 1
Functional Analysis of Protein Targets by Metabolomic Approaches
Kim, Y., & Saghatelian, A. (2011) · Topics in current chemistry · doi:10.1007/128_2011_284 · Cited by 1
The Management of Neuropathic Pain
Toth, C., & Moulin, D. E. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139152211.019 · Cited by 1
Woyach, V. L., Sherman, K., Hillard, C. J., Hopp, F. A., Hogan, Q. H., & Dean, C. (2022) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00073.2022 · Cited by 1
3D-QSAR study of benzotriazol-1-yl carboxamide scaffold as monoacylglycerol lipase inhibitors
Bawa, S., Afzal, O., Kumar, S., Kumar, R., & Jaggi, M. (2014) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.142957 · Cited by 1
Katz, P. S., Edwards, S., & Molina, P. E. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1071-7_23 · Cited by 1
Targeting the Endocannabinoid Metabolic Enzymes to Reduce Inflammatory Pain
Ghosh, S. (2014) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/ngv2-th75 · Cited by 1
Olango, W. M. (2012) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17506 · Cited by 1
Nass, S. R. (2015) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6297 · Cited by 1
Lehmann, C., Cerny, V., & Matějovič, M. (2011) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-642-18081-1_2
Role of the Endocannabinoid System in Systems Toxicity
Pistos, C. M., & Theocharis, S. E. (2009) · General, Applied and Systems Toxicology · doi:10.1002/9780470744307.gat206
The endocannabinoid system : a translational study from Achilles tendinosis to cyclooxygenase
Björklund, E. (2014) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Hunerdosse, D. M. (2015) · eScholarship (California Digital Library)
Accumulation and metabolism of neutral lipids in obesity
Douglass, J. D. (2014) · doi:10.7282/t3d798hp
Muthuraman, A. (2012) · INFLIBNET
Ware, M. A. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139152211.022
Philosophy at Virginia Commonwealth University.
Booker, L. (2011)
Metadata
- Authors
- Kinsey, S. G., Long, J. Z., O’Neal, S. T., Abdullah, R. A., Poklis, J. L., Boger, D. L., Cravatt, B. F., & Lichtman, A. H.
- Affiliations
- Virginia Commonwealth University (US)
- Scripps Research Institute (US)
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 330
- Issue
- 3
- Pages
- 902-910
- ISSN
- 0022-3565 (ISSN-L)
- PMC
- PMC2729802
- OpenAlex
- W2132380973
- Cited by
- 330
- References
- 43
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 13 · 2023: 8 · 2022: 7 · 2021: 15 · 2020: 9 · 2019: 14 · 2018: 21 · 2017: 24 · 2016: 16 · 2015: 21 · 2014: 35 · 2013: 29 · 2012: 33
- FWCI
- 24.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institute of International Education
- National Institute on Drug Abuse (DA015197, P01DA009789, DA-017259, R01DA015197, DA009789-11, DA007027-32, P01DA017259, DA 009789, DA015648, T32DA007027, DA007027)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- neuropathic pain, endocannabinoid system, fatty acid amide hydrolase, monoacylglycerol lipase, anandamide, 2-arachidonoylglycerol, CB1 receptor, CB2 receptor, URB597, JZL184, chronic constriction injury, mechanical allodynia, cold allodynia, analgesic drug development
- MeSH terms
- Fatty Acid Amide Hydrolases, Amidohydrolases, Animals, Arachidonic Acids, Benzamides, Carbamates, Cold Temperature, Enzyme Inhibitors, Glycerides, Hyperalgesia, Male, Mice, Inbred C57BL, Monoacylglycerol Lipases, Narcotic Antagonists, Pain, Pain Measurement, Peripheral Nervous System Diseases, Piperidines, Pyridines, Analgesics, Non-Narcotic, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2, TRPV Cation Channels, Mice, Benzodioxoles, Polyunsaturated Alkamides, Cannabinoid Receptor Modulators, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review